A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia | Alzheimer's Research & Therapy | Full Text

A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia | Alzheimer's Research & Therapy | Full Text

A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia

Sodium oligomannate (GV-971), a marine-derived oligosaccharide, is a novel agent that may improve cognition in AD patients.

Authors:Tao Wang, Weihong Kuang, Wei Chen, Wenwei Xu, Liming Zhang, Yingjie Li, Hailin Li, Ying Peng, Yangmei Chen, Baojun Wang, Jinsong Xiao, Honghua Li, Chuanzhu Yan, Yifeng Du, Mouni Tang, Zhiyi He…

Citation:Alzheimer's Research & Therapy 2020 12:110

Content type:Research

 

Published on: 14 September 2020

• ViewFull Text
 
• ViewPDF